Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/11/17 → 8/11/20 |
Funding
- INC Research, LLC (Prot #BP39365 // Prot #BP39365)
- Roche TCRC, Inc. (Prot #BP39365 // Prot #BP39365)
Prot #BP39365: An Open-Label, Multi-Center, Randomized, Dose-Escalation, Phase IB Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281, in Combination with Atezolizumab ± Bevacizumab, Following Obinutuzumab Pre-Treatment, in Pa
- Sosman, Jeffrey Alan (PD/PI)
Project: Research project